lamellarin alpha: antioxidant from the Indian ascidian Didemnum obscurum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 11477790 |
CHEMBL ID | 1928864 |
MeSH ID | M0472037 |
Synonym |
---|
CHEMBL1928864 |
lamellarin alpha |
7-hydroxy-12-(3-hydroxy-4-methoxyphenyl)-8,16,17-trimethoxy-4-oxa-1-azapentacyclo[11.8.0.02,11.05,10.014,19]henicosa-2(11),5,7,9,12,14,16,18,20-nonaen-3-one |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID635408 | Cellular uptake in human HeLa cells expressing CD4 at 100 uM after 24 hrs by confocal laser scanning microscopy analysis in presence of methanol | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24 | Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues. |
AID635405 | Antiviral activity against LacZ-containing HIV1 in COS7 cells expressing HXB2 Env, R8.91, and pTY-EFnLacZ assessed as reduction of viral vector infection into human HeLa cells expressing CD4 after 2 days using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyra | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24 | Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues. |
AID635407 | Cellular uptake in human HeLa cells expressing CD4 at 100 uM after 24 hrs by confocal laser scanning microscopy analysis | 2011 | Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24 | Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.87) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |